For comments, suggestions
Created with Raphaël 2.1.0 07.03.2019 Filing date 07.10.2020 Validation fee payment 28.02.2021 (A1) Patent application published 19.02.2024 AGEPI application filing date 30.09.2024 (T2) Translation of the validated European patent 25.04.2025 07.03.2026 Valid until 08.03.2027 Renewal fee to be paid until 07.03.2039 Patent will expire on

Patent in force


(210)Number of the EPO application19765136
(220)Filing date of the EPO application2019.03.07
(80)EPO patent specification publication (B)EPB nr. 48/2023, 2023.11.29
(110)EPO patent number3761980
(11)Number of the documentMD 3761980 T2
(21)Number of the applicatione 2021 0065
(71)Name(s) of applicant(s), code of the countryPLIANT THERAPEUTICS, INC., US;
(72)Name(s) of inventor(s), code of the countryCHA Jacob, US;
DONG Chengguo, US;
HOM Timothy, US;
JIANG Lan, US;
LEFTHERIS Katerina, US;
LI Hui, US;
MORGANS JR. David J., US;
MUNOZ Manuel, US;
REILLY Maureen, US;
ZHENG Yajun, US;
BAILEY Christopher, US;
FINKELSTEIN Darren, US;
(73)Name(s) of owner(s), code of the countryPLIANT THERAPEUTICS, INC., US;
(54)Title of the inventionAmino acid compounds and methods of use
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/4375 (2006.01.01); C07D 401/12 (2006.01.01); A61P 43/00 (2006.01.01); C07D 471/04 (2006.01.01); C07D 519/00 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2021.02.28
(49)Date of publication of the translation of the validated European patent specification2024.09.30
(30)Priority201862639988 P, 2018.03.07, US; 201862690933 P, 2018.06.27, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/US2019/021243, 2019.03.07
(87)International publicationWO 2019/173653, 2019.09.12
Up
/Inventions/details/3761980